Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

Stock Recap
#PipelineProspector

Ezetimibe

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

130 API Suppliers, 29 USDMF, 11 JDMF, 18 EU WC, 73 KDMF, 19 NDC API, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

151 Drugs in Development

151 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

621 FDF Dossiers, 70 FDA Orange Book, 356 Europe, 20 Canada, 25 Australia, 42 South Africa, 108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 6 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Kirsch Pharma, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 19 BASF, 2 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 34 Direct Compression, 32 Granulation, 22 Lubricants & Glidants, 20 Thickeners and Stabilizers, 19 Controlled & Modified Release, 12 Chewable & Orodispersible Aids, 10 Taste Masking, 10 Co-Processed Excipients, 9 Solubilizers, 8 Film Formers & Plasticizers, 7 Parenteral, 6 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

116 News #PharmaBuzz

116 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 329 Regulatory FDF Prices, 65 Annual Reports

MARKET PLACE

22 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents, 3 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 4 Others

ANALYTICAL

6 BioAnalytical Methods

6 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
19/09/2025	Dr. Reddy's Laboratories	India	M/s Dr Reddy's Laboratories Limited	WC-0067	Ezetimibe IH/USP	2025-07-15	2028-07-07	Chemical Technical Operation
19/09/2025	Neuland Laboratories	India	M/sNeuland Laboratories ltd	WC-0037	Ezetimibe IH/USP	2025-06-27	2028-06-16	Unit-ll, Plot No. 92-94, 257-259, IDA Pashamylaram, Pashamylaram Village, Patancheru Mandal, Sangareddy District, Pin code-502 307, Telangana State, India

Ezetimibe

Ezetimibe

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

130 API Suppliers

29 USDMF

11 JDMF

18 EU WC

73 KDMF

19 NDC API

50 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

151 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

621 FDF Dossiers

70 FDA Orange Book

356 Europe

20 Canada

25 Australia

42 South Africa

108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG

TABLET;ORAL - 10MG;10MG

TABLET;ORAL - 10MG;20MG

TABLET;ORAL - 10MG;40MG

TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

2 Minakem

6 SPI Pharma

6 DKSH

5 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

3 Kirsch Pharma

1 ACG Worldwide

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

19 BASF

2 CD Formulation

10 Corel Pharma Chem

7 DFE Pharma

8 Gangwal Chemicals

4 Ideal Cures

4 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

3 Nitika Pharmaceutical Specialities

3 Novo Excipients

5 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons